IGF2 and cancer: In order to test whether EphB4 and the autocrine IGF-II system were part of a common mechanism in cancer, we profiled a number of cancer cell lines for the expression of the IGF-II loop autocrine components combining both known data with experimental validation (Table 1 and Fig. 1).